Jennifer G. Robinson
New England Journal of Medicine · 2011–2016
A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Jennifer G. Robinson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jennifer G. Robinson overall
Papers from Jennifer G. Robinson's perspective
Ordered by how strongly the researchers Jennifer G. Robinson trusts endorse each paper. Same corpus, a different order for every researcher.
- Bagging Predictors
- Rosuvastatin in older patients with systolic heart failure. (Current Atherosclerosis Reports)
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (New England Journal of Medicine)
- Statin safety: a systematic review. (American Journal of Cardiology)
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans (Nature Genetics)
- Experiments with a New Boosting Algorithm
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (Journal of the American College of Cardiology)
- Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. (New England Journal of Medicine)
- Intensive versus moderate lipid lowering with statins after acute coronary syndromes. (New England Journal of Medicine)
Their papers
- Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. (2013) — 199 citations
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (2015) — 671 citations
- Generalized Inverse Classification (2016) — 68 citations
- Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. (2015) — 1,138 citations
- Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. (2015) — 2,054 citations
- Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease (2014) — 861 citations
- Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (2014) — 2,241 citations
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) — 5,681 citations
- ACCF/AHA TASK FORCE MEMBERS (2013) — 770 citations
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis (2012) — 1,018 citations
- Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. (2011) — 735 citations